Cargando…

Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial

BACKGROUND: Rates of surgical site infections (SSIs) following groin incision for femoral artery exposure are much higher than expected of a clean operation. The morbidity and mortality is high, particularly with the use of prosthetic grafts. The vascular surgery population is at an increased risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Patrick, Lee, Kevin, Dubois, Luc, DeRose, Guy, Forbes, Thomas, Power, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634141/
https://www.ncbi.nlm.nih.gov/pubmed/26537879
http://dx.doi.org/10.1186/s13063-015-1026-1
_version_ 1782399299058925568
author Murphy, Patrick
Lee, Kevin
Dubois, Luc
DeRose, Guy
Forbes, Thomas
Power, Adam
author_facet Murphy, Patrick
Lee, Kevin
Dubois, Luc
DeRose, Guy
Forbes, Thomas
Power, Adam
author_sort Murphy, Patrick
collection PubMed
description BACKGROUND: Rates of surgical site infections (SSIs) following groin incision for femoral artery exposure are much higher than expected of a clean operation. The morbidity and mortality is high, particularly with the use of prosthetic grafts. The vascular surgery population is at an increased risk of SSIs related to peripheral vascular disease (PVD), diabetes, obesity, previous surgery and presence of tissue loss. Negative pressure wound therapy (NPWT) dressings have been used on primarily closed incisions to reduce surgical site infections in other surgical disciplines. We have not come across any randomized controlled trials to support the prophylactic use of negative pressure wound therapy in high-risk vascular patients undergoing lower limb revascularization. METHODS/DESIGN: In this single-center, prospective randomized controlled trial, patients scheduled for a lower limb revascularization requiring open femoral artery exposure who are at a high risk (BMI > 30 kg/m(2), previous femoral cutdown or Rutherford V or VI category for chronic limb ischemia) will be eligible for the study. A total of 108 groin incisions will be randomized to the use of a negative pressure wound device or standard adhesive gauze dressing. Patients will be followed in hospital and reassessed within the first 30 days postoperatively. The primary outcome is SSI within the first 30 days of surgery and will be determined using the intention-to-treat principle. Secondary outcomes include length of stay, emergency room visits, reoperation, amputation and mortality. A cost analysis will be performed. DISCUSSION: The trial is expected to define the role of NPWT in SSI prophylaxis for lower limb revascularization in high-risk vascular patients. The results of the study will be used to inform current best practice for perioperative care and the minimization of SSIs. TRIAL REGISTRATION: NCT02084017, March 2014
format Online
Article
Text
id pubmed-4634141
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46341412015-11-06 Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial Murphy, Patrick Lee, Kevin Dubois, Luc DeRose, Guy Forbes, Thomas Power, Adam Trials Study Protocol BACKGROUND: Rates of surgical site infections (SSIs) following groin incision for femoral artery exposure are much higher than expected of a clean operation. The morbidity and mortality is high, particularly with the use of prosthetic grafts. The vascular surgery population is at an increased risk of SSIs related to peripheral vascular disease (PVD), diabetes, obesity, previous surgery and presence of tissue loss. Negative pressure wound therapy (NPWT) dressings have been used on primarily closed incisions to reduce surgical site infections in other surgical disciplines. We have not come across any randomized controlled trials to support the prophylactic use of negative pressure wound therapy in high-risk vascular patients undergoing lower limb revascularization. METHODS/DESIGN: In this single-center, prospective randomized controlled trial, patients scheduled for a lower limb revascularization requiring open femoral artery exposure who are at a high risk (BMI > 30 kg/m(2), previous femoral cutdown or Rutherford V or VI category for chronic limb ischemia) will be eligible for the study. A total of 108 groin incisions will be randomized to the use of a negative pressure wound device or standard adhesive gauze dressing. Patients will be followed in hospital and reassessed within the first 30 days postoperatively. The primary outcome is SSI within the first 30 days of surgery and will be determined using the intention-to-treat principle. Secondary outcomes include length of stay, emergency room visits, reoperation, amputation and mortality. A cost analysis will be performed. DISCUSSION: The trial is expected to define the role of NPWT in SSI prophylaxis for lower limb revascularization in high-risk vascular patients. The results of the study will be used to inform current best practice for perioperative care and the minimization of SSIs. TRIAL REGISTRATION: NCT02084017, March 2014 BioMed Central 2015-11-04 /pmc/articles/PMC4634141/ /pubmed/26537879 http://dx.doi.org/10.1186/s13063-015-1026-1 Text en © Murphy et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Murphy, Patrick
Lee, Kevin
Dubois, Luc
DeRose, Guy
Forbes, Thomas
Power, Adam
Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial
title Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial
title_full Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial
title_fullStr Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial
title_full_unstemmed Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial
title_short Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial
title_sort negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634141/
https://www.ncbi.nlm.nih.gov/pubmed/26537879
http://dx.doi.org/10.1186/s13063-015-1026-1
work_keys_str_mv AT murphypatrick negativepressurewoundtherapyforhighriskwoundsinlowerextremityrevascularizationstudyprotocolforarandomizedcontrolledtrial
AT leekevin negativepressurewoundtherapyforhighriskwoundsinlowerextremityrevascularizationstudyprotocolforarandomizedcontrolledtrial
AT duboisluc negativepressurewoundtherapyforhighriskwoundsinlowerextremityrevascularizationstudyprotocolforarandomizedcontrolledtrial
AT deroseguy negativepressurewoundtherapyforhighriskwoundsinlowerextremityrevascularizationstudyprotocolforarandomizedcontrolledtrial
AT forbesthomas negativepressurewoundtherapyforhighriskwoundsinlowerextremityrevascularizationstudyprotocolforarandomizedcontrolledtrial
AT poweradam negativepressurewoundtherapyforhighriskwoundsinlowerextremityrevascularizationstudyprotocolforarandomizedcontrolledtrial